Skip to main content
×
×
Home

Active monitoring of 12760 clozapine recipients in the UK and Ireland: Beyond pharmacovigilance

  • Janet Munro (a1), Desmond O'Sullivan (a2), Christopher Andrews (a2), Alejandro Arana (a3), Ann Mortimer (a4) and Robert Kerwin (a1)...
Abstract
Background

People prescribed clozapine for treatment-resistant schizophrenia have mandatory haematological monitoring through a case register for identifying reversible neutropenia.

Aims

To quantify risk factors for agranulocytosis in subjects receiving clozapine.

Method

Data from 12 760 subjects registered to receive clozapine from January 1990 to April 1997 were analysed. Risk factors for agranulocytosis were quantified using a Cox proportional-hazards regression analysis.

Results

The risk for agranulocytosis in Asian subjects was 2.4 times that in Caucasians (P=0.03). There was an age-related increase in risk of 53% per decade (P=0.0001).

Conclusions

The case register yielded valuable information for guiding research into the causes of the haematological reactions.

Copyright
Corresponding author
Dr R. Kerwin, Institute of Psychiatry, De Crespigny Park, London SE5 8AF
Footnotes
Hide All

Declaration of interest

The Clozaril Patient Monitoring Service is part of Novartis Pharmaceuticals. Three authors (D.O'S., C. A., A. A.) are employed by Novartis and three (J. M., A. M., R. K.) are in receipt of research grants from the company.

Footnotes
References
Hide All
Alvir, J. J., Lieberman, J. A., Schwimmer, J. L., et al (1993) Clozapine-induced agranulocytosis: incidence and risk factors in the United States. New England Journal of Medicine, 329, 162167.
Anderson, C., Connelly, J., Johnstone, E. C., et al (1991) Disabilities and circumstances of schizophrenic patients – a follow-up study. V: Cause of death. British Journal of Psychiatry, 159 (suppl. 13), 3033.
Atkin, K, Kendall, F., Gould, D., et al (1996) Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. British Journal of Psychiatry, 169, 483488.
Black, D. W. & Fisher, R. (1992) Mortality in DSM–III–R schizophrenia. Schizophrenia Research, 7, 109116.
Breslow, N. E. & Day, N. E. (1987) Statistical Methods in Cancer Research. Volume II: The Design and Analysis of Cohort Studies, pp. 6972. Lyon: International Agency for Research on Cancer.
Cytet Software (1995) StatXact-3 for Windows. Cambridge, MA: Cytel Software Corporation.
Harris, E. C. & Barractough, B. (1998) Excess mortality of mental disorder. British Journal of Psychiatry, 173, 1153.
Helgason, L. (1990) Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatrica Scandinavica, 81, 231235.
Honigfeld, G. (1996) Effects of the Clozapine National Registry System on incidence of deaths related to agranulocytosis. Psychiatric Services, 47, 52 56.
Meitzer, H. Y. & Okayli, G. (1995) Reduction of suicidally during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk–benefit assessment. American Journal of Psychiatry, 152, 183190.
Mortansen, P. B. & Juel, K. (1993) Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry, 163, 183189.
Newman, S. C. & Bland, R. C. (1991) Mortality in a cohort of patients with schizophrenia: a record linkage study. Canadian Journal of Psychiatry, 36, 239245.
Office for National Statistics (1995) Mortality Statistics: General, England and Wales, 1993, 1994, 1995. London: HMSO.
Registrar General (1997) Review of the Registrar General on Deaths in England and Wales, 1993–1995. Series DHI, no. 28. London: Stationery Office.
SAS Institute (1996) SAS/STAT. Version 6.12. Cary, NC: SAS Institute.
Tsoi, W. F. & Wong, K. E. (1991) A 15-year follow-up study of Chinese schizophrenic patients. Acta Psychiatrica Scandinavica, 84, 217220.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 50 *
Loading metrics...

Abstract views

Total abstract views: 328 *
Loading metrics...

* Views captured on Cambridge Core between 3rd January 2018 - 20th August 2018. This data will be updated every 24 hours.

Active monitoring of 12760 clozapine recipients in the UK and Ireland: Beyond pharmacovigilance

  • Janet Munro (a1), Desmond O'Sullivan (a2), Christopher Andrews (a2), Alejandro Arana (a3), Ann Mortimer (a4) and Robert Kerwin (a1)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *